Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Lowe

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Regulatory Peptides|July 2, 1993
Discovery of CP-96,345 and its characterization in disease models involving substance PJ A Lowe, S E Drozda, R M Snider, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
Journal of Medicinal Chemistry|February 1, 1991
Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesteraseJ A Lowe, R L Archer, D S Chapin, et al.
Science (New York, N.Y.)|January 25, 1991
A potent nonpeptide antagonist of the substance P (NK1) receptorR M Snider, J W Constantine, J A Lowe, et al.
Journal of Medicinal Chemistry|June 1, 1991
1-Naphthylpiperazine derivatives as potential atypical antipsychotic agentsJ A Lowe, T F Seeger, A A Nagel, et al.
Journal of Medicinal Chemistry|January 5, 1996
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agentsH R Howard, J A Lowe, T F Seeger, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
A new class of selective and potent inhibitors of neuronal nitric oxide synthaseJ A Lowe, W Qian, R A Volkmann, et al.
Earth'S Future|January 2, 2023
A High-End Estimate of Sea Level Rise for PractitionersR S W van de Wal, R J Nicholls, D Behar, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Regulatory Peptides|July 2, 1993
Discovery of CP-96,345 and its characterization in disease models involving substance PJ A Lowe, S E Drozda, R M Snider, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
Journal of Medicinal Chemistry|February 1, 1991
Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesteraseJ A Lowe, R L Archer, D S Chapin, et al.
Science (New York, N.Y.)|January 25, 1991
A potent nonpeptide antagonist of the substance P (NK1) receptorR M Snider, J W Constantine, J A Lowe, et al.
Journal of Medicinal Chemistry|June 1, 1991
1-Naphthylpiperazine derivatives as potential atypical antipsychotic agentsJ A Lowe, T F Seeger, A A Nagel, et al.
Journal of Medicinal Chemistry|January 5, 1996
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agentsH R Howard, J A Lowe, T F Seeger, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
A new class of selective and potent inhibitors of neuronal nitric oxide synthaseJ A Lowe, W Qian, R A Volkmann, et al.
Earth'S Future|January 2, 2023
A High-End Estimate of Sea Level Rise for PractitionersR S W van de Wal, R J Nicholls, D Behar, et al.
Pageof 9